SUMMARY. Serologic testing of wild birds for avian influenza virus (AIV) surveillance poses problems due to species differences and nonspecific inhibitors that may be present in sera of wild birds. Recently available competitive enzyme-linked immunosorbent assay (cELISA) kits offer a new species-independent approach. In this study we compare two commercial competitive cELISAs, using a total of 184 serum and plasma samples from 23 species of wild birds belonging to 10 orders. Thirteen samples were from experimentally high pathogenicity AI and low pathogenicity AI infected red-legged partridges (Alectoris rufa), 77 samples were from a flock of sentinel hybrid ducks confirmed infected by AI by real-time PCR, and 94 samples were from wild birds admitted to a rehabilitation center. Both ELISAs detected AI antibodies in the experimentally infected partridges, whereas hemagglutination inhibition (HI) was negative. Concordance in results between the two ELISAs was 51.5%. When specific subtype-H5/H7 HI-positive samples were considered for comparison, ELISA 1 appeared to perform better on ducks, whereas ELISA 2 appeared to perform better in other wild bird species. Overall, 68.2% of H5/H7 positive samples tested positive by ELISA 1 and 36% by ELISA 2. Both ELISAs detected AIV-antibody-positive samples negative by specific HI against 9 of the 16 existing hemagglutinin (HA) subtypes. Presumably this reflects either higher sensitivity of cELISA when compared to HI, presence of antibodies against HA subtypes not tested, or unspecific reactions. Performance of ELISA 1 on ducks appears to be comparable to in-house cELISA previously used by other authors in wild birds, but requires a relatively large sample volume. Alternatively, although ELISA 2 required a smaller sample volume, it was less effective at identifying HI-positive samples. The results reflect the necessity of validation of cELISA tests for individual species or at least families, as required by the OIE. RESUMEN. Nota de Investigación-Análisis serológicos de los virus de la influenza aviar en aves silvestres. Comparación de dos ensayos competitivos de inmunoabsorción con enzimas ligadas disponibles comercialmente.
The continuing avian influenza epidemic due to subtype H5N1 has resulted in commitment of resources toward improving avian influenza virus (AIV) detection tools, especially in wild birds, as they are considered the natural reservoir of all hemagglutinin and neuraminidase subtypes of influenza A viruses (5) .
Serologic testing is widely used for surveillance and disease control in domestic poultry, employing mainly agar gel immunodiffusion (AGID) and indirect enzyme-linked immunosorbent assay (iELISA) systems as prescreening tools and the hemagglutination inhibition (HI) test as a confirmation assay, because it is considered the serologic standard method.
Nevertheless, some constraints exist in relation to serologic testing in wild birds. AGID tests can be useful when screening large numbers of birds, although it has not been thoroughly validated for use with other than gallinaceous species and has been shown to yield inconsistent results in some species, such as mallards, that do not always produce precipitating antibodies (7, 8, 13) . HI provides information on the presence of antibodies directed against specific subtypes of AIV and can be applied to a variety of bird species. However, to avoid the effect of nonspecific inhibitors, the sera need to be pretreated, potentially causing a decrease of antibody titers. Other constraints of the use of HI are related to steric inhibition from the antibodies to the neuraminidase (NA) protein that can affect the interaction of the hemagglutinin (HA) protein and the antibodies directed to it, and the facts that it is expensive, very labor intensive, and not readily applicable to high-throughput testing (13). An additional problem in serologic testing in wild birds is the amount of serum or plasma needed in the test systems, which frequently exceeds the maximum volume that can be extracted without harming lowerbody-mass individuals, especially small songbirds.
For high-throughput screening of poultry, ELISAs have been developed to detect mainly anti-nucleoprotein (NP) antibodies directed against a cross-reactive antigen shared by all influenza A viruses. However, most of the current commercial immunoenzymatic tests are based on indirect detection of specific antibodies using antispecies conjugates. These tests mostly employ anti-chicken IgG secondary antibodies and thus can generally not be employed to test wild bird samples (4) . Some groups have tried approaches using peroxidase-labeled anti-chicken IgA conjugate produced in rabbits with good results for the species tested, but the system has not been taken to a commercial format (1, 2) .
More recently, competitive ELISA (cELISA) systems have been implemented to detect antibodies against AI NP in different avian species (12, 14) . This refined species-independent approach has been used for wildlife surveillance (6, 7) , and is now commercially available.
Generally, validation of these tests is carried out with influenzaantibody-positive samples obtained during experimental infections, as this way specific antibody titers and HA subtype against which they are directed are known (12, 14) . However, this means that only a reduced number of species is included in validation studies and in effect, the OIE standards (12) recommend these tests to be validated for each species tested. This has the inconvenience that in most cases only a limited number and amount of samples are available.
Recently, the first validation of a commercial blocking ELISA (bELISA) (IDEXX) using 281 sera from experimentally infected and sham-inoculated wild bird species has been reported. Results obtained from the bELISA as compared to AGID revealed the usefulness of the kit as a preliminary screening tool and as a complement to agent identification methods (3). However, this kit was not evaluated with field samples, in which antibody response is expected to be lower than in experimental infections.
The aim of this study is to compare results from two commercial cELISAs, first with sera from experimentally infected red-legged partridges (Alectoris rufa), then with plasma samples from a group of sentinel ducks confirmed infected by LPAI with the use of real-time polymerase chain reaction (RT-PCR), and finally with samples from different species of wild birds, with the aim of assessing the usefulness of this kind of assay in wild bird disease surveillance.
MATERIALS AND METHODS
In our study, we employed three different sample sets. A small number of sera (n 5 13) were available from a recently completed infection experiment that used low and high pathogenic H7 subtype avian influenza virus in red-legged partridges (Table 3) . Briefly, the samples were from three control birds, five partridges infected with H7N9 LPAI on day 15 pi, just prior to euthanasia, and five partridges infected with H7N1 HPAI on days 5, 6, and 8 pi.
A total of 77 plasma samples were available from a flock of sentinel ducks (mallard hybrids, included in Tables 1 and 2 as Anas sp.) in which LPAI infection had been confirmed by RT-PCR. The third set of samples originated from a plasma bank collected between 1995 and 2007 from birds of prey, white storks, and other water birds admitted to rehabilitation centers in Castilla-La Mancha in south central Spain. The sample type available for all individual birds from the field was plasma, as the extracting veterinarians used a single tube for blood extraction in order to maximize sample yield.
A total of 1400 plasma samples from the wild bird plasma bank and from sentinel ducks were tested against H5 and H7 subtype AIV with the HI test, with four hemagglutinating units (HU) as described previously (11; data not shown). The red-legged partridge sera were tested by HI against H7 subtype AIV only. Antigen for HI testing had been purchased from the influenza A virus reference laboratory of the OIE (Veterinary Laboratories Agency, VLA New Haw, Addlestone, United Kingdom). Antigens available for primary screening were H7N1 (A/African Starling/983/79) and H5N2 (A/Ostrich/Denmark/72420/ 96). Positive sera were then confirmed with H5N1 (A/Chicken/ Scotland/59) and H7N7 (A/Turkey/England/647/77) antigens. All antigens had been produced in specific-pathogen-free embryonated chicken eggs and were provided lyophilized. Prior to analysis all samples were inactivated 30 min at 56 C. Samples with a HI titer $1.16 were considered positive.
A subset of 94 plasma samples of wild birds was selected to include a considerable number of AIV-antibody-positive samples (as by H5/H7-subtype HI), and where possible, also a minimum of randomly selected HI (H5/H7) negative samples from individuals of the same species and families. Twenty-three species belonging to 10 families were included in this study.
The samples were analyzed blindly with two different ELISAs (ELISA 1 Ingezim Influenza AH, Ingenasa, Spain; ELISA 2 IDscreen, influenza A antibody competitionH, Idvet, France). ELISA 1 is based on a blocking protocol and ELISA 2 is based on a competition protocol. ELISA kits were used according to manufacturer's instructions. HI-test positive samples that tested negative with ELISA 2 were retested, including an overnight incubation period, as described by the manufacturer for problem samples.
A sample was considered doubtful if the competition percentage was between 45% and 50% in the case of ELISA 1 and between 40% and 45% in ELISA 2, as defined by manufacturers. For subsequent comparisons, doubtful samples were considered positive. Finally, 49 plasma samples that tested positive in one or both of the ELISAs but negative in the HI test against H5 and H7 antigen, were submitted to HI tests against other HA subtypes, depending on the availability of sample. HA subtypes against which the problem samples were tested included H1, H2, H3, H6, H9, H10, and H12. HI tests for these additional HA antigens were carried out at the virology department of the Klinik für Vögel, Amphibien, Fische und Reptilien of the veterinary faculty in Giessen, Germany.
RESULTS
In the red legged partridge samples included in the study, H7 AIV subtype infection was confirmed by RT-PCR on feathers and swabs on consecutive days. AIV antibodies were detected by both cELISAs, but not by the HI test (Table 3) . Concordance between the two ELISAS was 53.8%.
Among the sentinel ducks, 62 samples (80.5%) tested positive by ELISA 1, while only 16 (20.8%) samples were identified as positive by ELISA 2 (Table 1) . HI confirmed 14 (22.2%) of the samples positive by ELISA 1 and 5 (31.3%) of the samples that had tested positive by ELISA 2. Two of the total of 17 samples that tested positive against H5 or H7 subtypes in HI (Table 1) were not detected by any of the two cELISAS. Concordance between the two ELISAS for the sentinel duck samples was 36.4%.
With ELISA 1, 14 (14.89%) of the 94 wild birds tested positive, and 38 (40.4%) of the birds tested positive by ELISA 2 ( Table 2) Concordance of AIV antibody detection between the HI test and cELISAS was not related to the titer in the HI test. Overnight None of the ELISA-positive/HI H5/H7-negative samples that could be tested against additional HA subtypes (n 5 49) gave a positive result. Due to the reduced amount of sample volume, it was not possible to test the samples against all HA subtypes. Thus HA AIV subtypes not tested in this study include: H4, H8, H11, H13, H14, H15, and H16. Also, AGID testing could not be carried out due to the lack of sample. H5/H7 HI negative but ELISA positive results were encountered in 8 of the 10 families included in the study.
DISCUSSION
Serologic testing of multiple different avian species for AIV antibodies is a challenge that the use of cELISA technology tries to solve (3, 15) .
In our study we compared the usefulness of recently available commercial multispecies ELISA kits for assessment of AIV seroprevalence in multiple wild bird species. ELISAs have been previously used in wild bird surveillance in Italy (6,7), but in this case an in-house double antibody sandwich blocking ELISA was employed that is not commercially available. Studies carried out in the 1990s in southern Spain employed an in-house iELISA based on anti-chicken IgA conjugate (1, 2) . A cELISA developed in the frame of the German AIV surveillance program was thoroughly tested and gave promising results, but again, is not available commercially (14). All these in-house ELISAs require extensive reagent production and manipulation, and thus may not be feasible in many laboratories (15), a situation that a commercially available kit using blocking ELISA technology could solve.
In this study, samples from 23 species of wild birds are included, most of which are related to wetland environments, considered the reservoir for AIV. Other predominantly terrestrial species included might become exposed to AIV through consumption of susceptible birds.
In our sample set, correlation between the cELISAs and HI and between the two cELISAS was variable. As the HI test and the blocking ELISAs investigated detect antibodies directed against different antigens, direct comparison is not appropriate. Therefore, we used proportion of concordance between the different tests for comparison.
Although a high concordance was observed between ELISA 1 and HI in duck samples, this test appeared to perform less well with other species. Correlation between HI and ELISA 2 was relatively poor for duck samples, but average in other bird species. However, the sample set available for comparative testing was limited and contained only five H5/H7-subtype HI-positive samples. In general, testing the samples by AGID also could have made interpretation of the results easier. Nevertheless, the small amount of sample available and the possibility that only part of the species might produce precipitating antibodies (13) led to the choice of HI as a comparative test.
In the case of ELISA 1 the manufacturers recommend the use of a volume of 50 ml for each sample. Given that this quantity exceeds in many cases the maximum volume that can be extracted without harming the individuals, this test is not very practical for small birds. ELISA 2, trying to improve this aspect, is configured for use with 10 ml of sample. This drastic volume reduction is of advantage for the analysis of wild bird samples, especially in songbirds. However, it might have negative effects on performance, especially in animals with low antibody titers. Despite the absence of a direct relation between specific HI titers and detection by either of the two ELISAs, sample dilution may be an important factor.
On the other hand, numerous samples tested positive by one or both of the ELISAs but were negative by HI against 9 of the 16 existing HA subtypes. Potentially, these samples may contain antibodies against any of the subtypes that were not tested, although some of these subtypes are fairly rare in the species and geographic sample location (8) . Also, nonspecific reactions or inhibition of the samples in the HI test system are possible, especially as in this case the material available was plasma. Nevertheless, authors that have developed and used cELISAs previously have encountered similar situations with field samples (6, 14) . Part of the samples employed by Starick et al. (14) in which this problem was observed were from experimentally infected ducks. HI positivity of consecutive samples, titration, and confirmation by an iELISA with a multispecies conjugate led these authors to conclude that in some of the cases the cELISA was more sensitive than HI. In field samples of ducks and geese tested thereafter by the same authors, this assumption was confirmed by titration curves of cELISA-positive/HI-negative samples, whereas in some other cases incongruent results between HI and ELISA were not resolved. However, the overall conclusion was that the test was very sensitive for flock screening as well as for the screening of wild bird samples (14).
Unfortunately, in our case, no further samples were available from experimentally infected red-legged partridges, because all partridges infected with HPAI had died by day 8 pi, whereas all LPAI-infected partridges were euthanatized on day 15 pi. Thus we suppose that the HPAI-infected partridges may not have had time to produce subtype-specific agglutinating antibodies. The performance of ELISA 1 and ELISA 2 on these samples was similar to the set of general wild bird samples.
In their study, Arenas et al.
(1) detected an AIV seroprevalence of 40% with an in-house iELISA based on anti-chicken IgA conjugate, in comparison to a 10% AIV seroprevalence in HI using HA subtypes H1, H3, H5, and H7. In a following study by researchers of the same group, using only the iELISA, overall AIV seroprevalence was much lower, namely, 6.2% (2) .
It has to be borne in mind that although the class ''birds'' is generally treated as a whole entity, it comprises a great variety of species, and therefore also a considerable variation in the immune response (3,10,14) . As an example, antibodies may be induced in ducks, as well as other anatid species, that cannot be detected in conventional HI test performed with intact virus (10, 14 Recently, a bELISA with a commercially available recombinant nucleoprotein antigen was tested successfully using samples of a variety of experimentally and naturally infected bird and mammal species (15), but comparative data of performance between the three tests is not yet available.
In conclusion, the cELISA system appears to be useful for the general screening of wild birds for AIV antibodies if it is kept in mind that results may vary with the species/family of bird tested and that specific validation as recommended by OIE may be necessary. In our case, ELISA 1 performed better on duck samples, whereas ELISA 2 did so in other bird species. Also, it could be interesting to amplify results by testing the cELISA-positive samples against specific HA and NA subtypes with the use of HI tests.
